t 0632 has been researched along with Pancreatitis in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Endo, T; Nagasaki, M; Shikano, T; Taniguchi, H; Yazaki, N; Yomota, E | 1 |
| Endo, T; Kume, E; Nagasaki, M; Shikano, T; Taniguchi, H; Yomota, E | 1 |
| Grendell, JH; Niederau, C | 1 |
3 other study(ies) available for t 0632 and Pancreatitis
| Article | Year |
|---|---|
Pharmacological profile of T-0632, a novel potent and selective CCKA receptor antagonist, in vivo.
Topics: Animals; Benzodiazepinones; Ceruletide; Devazepide; Dogs; Female; Gastric Emptying; Indoles; Male; Pancreas; Pancreatitis; Pregnancy; Proglumide; Rats; Rats, Sprague-Dawley; Receptor, Cholecystokinin A; Receptors, Cholecystokinin; Sincalide | 1996 |
Effect of T-0632, a cholecystokininA receptor antagonist, on experimental acute pancreatitis.
Topics: Acute Disease; Amylases; Animals; Ceruletide; Disease Models, Animal; Dogs; Esters; Female; Gabexate; Guanidines; Hormone Antagonists; Indoles; Ligation; Male; Pancreatic Ducts; Pancreatitis; Proglumide; Protease Inhibitors; Rats; Rats, Sprague-Dawley; Rats, Wistar; Receptor, Cholecystokinin A; Receptors, Cholecystokinin | 1997 |
Role of cholecystokinin in the development and progression of acute pancreatitis and the potential of therapeutic application of cholecystokinin receptor antagonists.
Topics: Acute Disease; Animals; Ceruletide; Cholecystokinin; Devazepide; Disease Models, Animal; Disease Progression; Humans; Indoles; Pancreatitis; Rats; Receptors, Cholecystokinin | 1999 |